Skip to main content

Are you Dr. Chong?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 53 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    750 NE 13th St
    Ste 300
    Oklahoma City, OK 73104
    Phone+1 405-235-0040
    Fax+1 405-235-4495

Summary

  • Dr. Laura Chong, MD is an allergist/immunologist in Oklahoma City, Oklahoma. She is currently licensed to practice medicine in Oklahoma, Maryland, and Wisconsin. She is affiliated with Oklahoma City VA Medical Center, INTEGRIS Deaconess, and Mercy Hospital Oklahoma City.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Allergy and Immunology, 2008 - 2010
  • University of Wisconsin Hospitals and Clinics
    University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 2004 - 2007
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 2004

Certifications & Licensure

  • OK State Medical License
    OK State Medical License 2011 - 2025
  • MD State Medical License
    MD State Medical License 2010 - 2012
  • WI State Medical License
    WI State Medical License 2006 - 2009
  • American Board of Allergy and Immunology Allergy & Immunology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Intergy EHR, Vitera Healthcare Solutions, LLC, 2013

Publications & Presentations

PubMed

Press Mentions

  • Oklahoma City Named 9th in Most Challenging Cities in the U.S. For Allergies
    Oklahoma City Named 9th in Most Challenging Cities in the U.S. For AllergiesMarch 11th, 2020
  • Experts Warn Oklahoma Allergy Sufferers’ Troubles Are Not Nearing an End
    Experts Warn Oklahoma Allergy Sufferers’ Troubles Are Not Nearing an EndSeptember 30th, 2019